May 2024 edition: Intuitive’s DV5, pediatric device design and diabetes tech


The Intuitive da Vinci 5’s top design changes: ‘This is groundbreaking for robotic surgery’ Small patients, big design challenges: Pediatric device experts guide engineers on solutions The biggest diabetes tech news out of ATTD 2024 5 things that will shape surgical robotics over the next decade All eyes on Intuitive’s da Vinci 5

It’s hard to think of a product update with higher stakes for a device developer — and the medtech industry — than Intuitive Surgical’s da Vinci 5 robotic-assisted surgery system.

All eyes are on the world’s leading surgical robotics developer as it rolls out the next generation of its flagship system after winning FDA clearance. Will the new features and long list of design changes put even more distance between surgical robotics and conventional laparoscopy? Is Intuitive advancing its technology rapidly enough to maintain or expand its lead ahead of larger device manufacturers, maturing surgical robotics developers and fas…

Read more
  • 0

CytexOrtho shares the ‘secret sauce’ for its absorbable hip implants

CytexOrtho uses a three-dimensional weaving process to make its ReNew Hip implants. Shown here is a close-up of the woven textiles. [Image courtesy of CytexOrtho]

CytexOrtho is developing absorbable orthopedic implants with a unique manufacturing method to help a rapidly growing patient population.

The ReNew Hip implant developer won the inaugural OrthoPitch tech innovation competition at AAOS 2024, beating out more than 40 other nominees.

CytexOrtho co-founder and CEO Brad Estes said the startup has filed its FDA investigational device exemption (IDE) for a phase one clinical trial in the U.S., he told Medical Design & Outsourcing after his recent DeviceTalks Weekly interview. The company plans to seek FDA premarket approval (PMA) after a larger phase two pivotal trial.

DeviceTalks live and in person: Registration is now open for DeviceTalks Boston (May 1-2)

CytexOrtho (incorporated as…

Read more
  • 0

CytexOrtho wins OrthoPitch Technology Competition at AAOS 2024

A computer-generated rendering from a CytexOrtho promotional video explains the company’s orthopedic implant technology. [Image courtesy of CytexOrtho]Durham, North Carolina–based CytexOrtho won the inaugural OrthoPitch Technology Competition at AAOS 2024 this week.

A pre-clinical stage medical device company, CytexOrtho’s ReNew Hip implant is designed to restore the joint naturally rather than replace it. It’s a potential solution for active people with early hip disease who are too young for a total hip replacement, according to AAOS.

CytexOrtho founder and CEO Bradley Estes explained during the pitch competition that surgeons remove only the damaged tissue, replacing it with the implant. The implant restores the joint to its proper form and contour. The implant slowly absorbs into the body while cells move into gaps in the implant’s layers and form functional tissue. The device has FDA Breakthrough Device designation. The company is comp…

Read more
  • 0

The biggest stories from AAOS 2024

The American Academy of Orthopaedic Surgeons’ annual meeting offers ortho tech companies the chance to present their latest innovations, and this year’s AAOS 2024 was no exception.

The event, running Feb. 12–16 in San Francisco, saw important announcements from companies including Stryker, Smith+Nephew, Osso VR and more.

Here are some highlights from AAOS 2024:

A new app for Stryker’s Mako The Mako robotic-assisted surgery system. [Image courtesy of Stryker]The world’s largest orthopedic device company says its Mako surgical robot for ortho procedures continues to drive growth, Stryker ended 2023 with 60% of its knee replacement procedures and 34% of its hip replacements in the U.S. performed using the robotic system.

Now, Stryker says it wants to further extend a surgeon’s Mako SmartRobotics experience in and beyond the operating room. The company used AAOS 2024 to highlight its myMako app for Apple Vision Pro and iPhone.


Read more
  • 0